It is known that mother cells are used as treatments for cancer, Parkinsons, spinal cord injury, type 1 diabetes, or Alzheimers diseases, among other. How could it be otherwise, nowadays also It has been revealed that these types of umbilical cord bodies could help people in the disease against COVID-19.

This information has been notified by the doctor Camilo Ricordi, director of Diabetes Research Institute (DRI) and from Cell Transplant Center at the University of Miami Miller School of Medicine, and his team of international collaborators (The Cure Alliance ), who have carried out an innovative test that has shown that Umbilical Cord Derived Mesenchymal Stem Cell (UC-MSC) Infusions Safely Reduce Risk of Death and Accelerate Recovery Time for the Most Severely Covid-19 Patients, as published in the magazine Stem Cells Translational Medicine (SCTM).

The study was cleared by the United States Food and Drug Administration (FDA) in April and started by The Cure Alliance, a organization non-profit, directed by Ricordi, of which research scientists are part who share knowledge with each other that serves to accelerate the cures of all kinds of diseases.

At the beginning of the pandemic, Ricordi created the Mini-Manhattan project, which has finally yielded important results on the possible treatment of stem cells from the umbilical cord to treat the disease of COVID-19 in people who have suffered serious consequences.

To conduct the study, the researchers analyzed the cases of 24 patients hospitalized at the University of Miami Tower and Jackson Memorial Hospital that they had developed severe acute respiratory distress because of coronavirus. As part of the trial, the scientists they tried giving two infusions of mesenchymal stem cells and placebos to hospitalized patients several days apart.

Its like the technology of a smart pump in the lungs to restore the normal immune response and reverse life-threatening complications, Ricordi notes in the study.

Our results confirm the powerful anti-inflammatory and immunomodulatory effect of UC-MSCs. These cells have clearly inhibited the cytokine storm, a hallmark of severe COVID-19. Add Giacomo Lanzoni, lead author of the research.

The results are critically important not only for COVID-19, but also for other diseases characterized by aberrant and hyper-inflammatory immune responses, such as autoimmune type 1 diabetes. We are eager to apply these cells in clinical trials to halt the progression of type 1 diabetes, he concludes. Lanzoni in Stem Cells Translational Medicine (SCTM)..

Follow this link:
COVID-19 : Coronavirus I The hopeful treatment against COVID-19 with stem cells from the umbilical cord - Explica